NASDAQ : CLYM
Climb Bio, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 10.25 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 588.72M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 22.86M | 21.17M | 15.39M | 9.89M | 18.92M | 12.35M |
| Research & Development | 41.90M | 46.71M | 11.61M | 11.58M | 26.21M | 23.32M |
| Operating Expenses | 64.76M | 67.88M | 27.00M | 21.47M | 45.13M | 35.67M |
| Operating Income | -64.76M | -67.88M | -27.00M | -21.47M | -45.13M | -35.67M |
| Interest & Investment Income | 7.23M | 8.32M | 8.13M | 2.29M | 1.20M | 450.00K |
| Currency Exchange Gain (Loss) | -98.00K | -291.00K | -9.00K | 536.00K | -1.48M | -170.00K |
| Other Non Operating Income (Expenses) | -11.72M | |||||
| EBT Excluding Unusual Items | -57.62M | -59.85M | -18.88M | -18.64M | -45.42M | -47.11M |
| Merger & Restructuring Charges | -3.36M | -18.81M | ||||
| Gain (Loss) on Sale of Investments | 2.33M | 177.00K | -370.00K | |||
| Pretax Income | -57.62M | -59.85M | -73.90M | -35.12M | -45.24M | -47.48M |
| Net Income | -57.62M | -59.85M | -73.90M | -35.12M | -45.24M | -47.48M |
| Preferred Dividends & Other Adjustments | 4.55M | |||||
| Net Income to Common | -57.62M | -59.85M | -73.90M | -35.12M | -45.24M | -52.03M |
| Shares Outstanding (Basic) | 69.03M | 66.69M | 48.16M | 26.99M | 26.31M | 12.26M |
| Shares Outstanding (Diluted) | 69.03M | 67.81M | 48.16M | 26.99M | 26.31M | 12.26M |
| EPS (Basic) | -0.83 | -0.90 | -1.53 | -1.30 | -1.72 | -4.24 |
| EPS (Diluted) | -0.83 | -0.90 | -1.53 | -1.30 | -1.72 | -4.24 |
| Free Cash Flow | -53.07M | -54.54M | -15.56M | -20.60M | -37.37M | -36.07M |
| Free Cash Flow Per Share | -0.77 | -0.80 | -0.32 | -0.76 | -1.42 | -2.94 |
| EBITDA | -64.63M | -67.79M | ||||
| D&A For EBITDA | 130.00K | 97.00K | ||||
| EBIT | -64.76M | -67.88M | -27.00M | -21.47M | -45.13M | -35.67M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 44.11M | 35.69M | 87.23M | 93.11M | 43.59M | 46.92M |
| Short-Term Investments | 139.02M | 65.39M | 63.69M | 13.69M | 79.98M | 89.56M |
| Cash & Short-Term Investments | 183.12M | 101.08M | 150.92M | 106.80M | 123.57M | 136.48M |
| Other Receivables | 2.46M | 6.59M | 7.02M | |||
| Receivables | 2.46M | 6.59M | 7.02M | |||
| Prepaid Expenses | 3.51M | 4.77M | 3.95M | 847.00K | 3.88M | 4.40M |
| Other Current Assets | 146.00K | 356.00K | 352.00K | |||
| Total Current Assets | 186.64M | 105.85M | 154.87M | 110.25M | 134.39M | 148.25M |
| Property, Plant & Equipment | 1.91M | 793.00K | 689.00K | 199.00K | 471.00K | |
| Long-Term Investments | 56.10M | 59.57M | 61.61M | 24.92M | ||
| Other Long-Term Assets | 1.65M | 1.53M | 16.00K | 15.00K | 128.00K | 70.00K |
| Total Assets | 246.29M | 167.74M | 217.19M | 110.47M | 134.99M | 173.24M |
| Accounts Payable | 1.13M | 2.27M | 705.00K | 66.00K | 750.00K | 1.40M |
| Accrued Expenses | 4.30M | 4.46M | 4.07M | 1.23M | 5.05M | 4.63M |
| Current Portion of Leases | 501.00K | 256.00K | 157.00K | 334.00K | 300.00K | |
| Other Current Liabilities | 1.20M | |||||
| Total Current Liabilities | 5.93M | 6.98M | 4.93M | 2.83M | 6.10M | 6.03M |
| Long-Term Leases | 813.00K | 285.00K | 375.00K | 15.00K | 180.00K | |
| Other Long-Term Liabilities | 22.00K | 7.00K | ||||
| Total Liabilities | 6.75M | 7.27M | 5.31M | 2.87M | 6.28M | 6.04M |
| Common Stock | 6.00K | 5.00K | 7.00K | 3.00K | 3.00K | 3.00K |
| Additional Paid-In Capital | 556.55M | 449.76M | 441.73M | 263.58M | 249.93M | 242.94M |
| Retained Earnings | -316.95M | -289.73M | -229.88M | -155.98M | -120.86M | -75.62M |
| Comprehensive Income & Other | -67.00K | 435.00K | 23.00K | -2.00K | -358.00K | -123.00K |
| Total Common Equity | 239.55M | 160.47M | 211.88M | 107.60M | 128.72M | 167.20M |
| Shareholders' Equity | 239.55M | 160.47M | 211.88M | 107.60M | 128.72M | 167.20M |
| Total Liabilities & Equity | 246.29M | 167.74M | 217.19M | 110.47M | 134.99M | 173.24M |
| Total Debt | 1.31M | 541.00K | 532.00K | 349.00K | 480.00K | |
| Net Cash (Debt) | 237.91M | 160.11M | 212.00M | 106.45M | 123.09M | 161.40M |
| Net Cash Per Share | 3.45 | 2.36 | 4.40 | 3.94 | 4.68 | 13.16 |
| Filing Date Shares Outstanding | 57.44M | 47.77M | 67.48M | 27.72M | 26.57M | 26.57M |
| Total Common Shares Outstanding | 57.44M | 47.77M | 67.26M | 27.70M | 26.57M | 26.24M |
| Working Capital | 180.70M | 98.86M | 149.94M | 107.42M | 128.30M | 142.22M |
| Book Value Per Share | 4.17 | 3.36 | 3.15 | 3.88 | 4.84 | 6.37 |
| Tangible Book Value | 239.55M | 160.47M | 211.88M | 107.60M | 128.72M | 167.20M |
| Tangible Book Value Per Share | 4.17 | 3.36 | 3.15 | 3.88 | 4.84 | 6.37 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -57.62M | -59.85M | -73.90M | -35.12M | -45.24M | -47.48M |
| Depreciation & Amortization | 130.00K | 97.00K | ||||
| Asset Writedown & Restructuring Costs | 51.66M | 180.00K | ||||
| Loss (Gain) From Sale of Investments | -1.73M | -2.27M | -757.00K | -2.33M | -177.00K | 370.00K |
| Stock-Based Compensation | 8.11M | 8.05M | 5.56M | 12.81M | 6.99M | 3.74M |
| Other Operating Activities | 169.00K | 219.00K | 178.00K | 101.00K | 851.00K | 11.47M |
| Change in Accounts Payable | 190.00K | 1.56M | -1.14M | -686.00K | -653.00K | 318.00K |
| Change in Other Net Operating Assets | -1.94M | -2.17M | 2.84M | 4.45M | 863.00K | -4.49M |
| Operating Cash Flow | -52.70M | -54.36M | -15.56M | -20.60M | -37.37M | -36.07M |
| Capital Expenditures | -369.00K | -186.00K | ||||
| Cash Acquisitions | -4.64M | |||||
| Investment in Securities | -29.05M | 3.02M | -111.45M | 68.98M | 34.44M | -114.97M |
| Investing Cash Flow | -29.42M | 2.83M | -121.09M | 68.98M | 34.44M | -114.97M |
| Issuance of Common Stock | 103.77M | 65.00K | 130.98M | 841.00K | 83.29M | |
| Other Financing Activities | -86.00K | -86.00K | -250.00K | |||
| Financing Cash Flow | 103.69M | -21.00K | 130.73M | 841.00K | 177.23M | |
| Foreign Exchange Rate Adjustments | 42.00K | 304.00K | -408.00K | 245.00K | ||
| Net Cash Flow | 21.57M | -51.54M | -5.88M | 49.53M | -3.34M | 26.43M |
| Free Cash Flow | -53.07M | -54.54M | -15.56M | -20.60M | -37.37M | -36.07M |
| Free Cash Flow Per Share | -0.77 | -0.80 | -0.32 | -0.76 | -1.42 | -2.94 |
| Levered Free Cash Flow | -33.99M | -33.32M | -9.54M | 3.46M | -20.51M | -25.30M |
| Unlevered Free Cash Flow | -33.99M | -33.32M | -9.54M | 3.46M | -20.51M | -25.30M |
| Change in Working Capital | -1.75M | -601.00K | 1.70M | 3.76M | 210.00K | -4.17M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 588.72M | 190.98M | 121.00M | 74.45M | 97.50M | 277.76M |
| Enterprise Value | 350.81M | 15.73M | -96.87M | -32.53M | -31.51M | 108.12M |
| Last Close Price | 10.25 | 4.00 | 1.80 | 2.70 | 3.67 | 10.46 |
| PB Ratio | 2.46 | 1.19 | 0.57 | 0.69 | 0.76 | 1.66 |
| P/TBV Ratio | 2.46 | 1.19 | 0.57 | 0.69 | 0.76 | 1.66 |
| Debt / Equity Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Debt / Equity Ratio | -0.99 | -1.00 | -1.00 | -0.99 | -0.96 | -0.96 |
| Net Debt / EBITDA Ratio | 3.68 | 2.36 | ||||
| Net Debt / FCF Ratio | 4.48 | 2.94 | 13.62 | 5.17 | 3.29 | 4.47 |
| Quick Ratio | 30.86 | 14.47 | 30.61 | 38.57 | 21.35 | 23.79 |
| Current Ratio | 31.45 | 15.16 | 31.41 | 38.92 | 22.04 | 24.58 |
| Return on Equity (ROE) | -27.10% | -32.15% | -46.26% | -29.72% | -30.58% | -50.16% |
| Return on Assets (ROA) | -18.45% | -22.04% | -10.30% | -10.93% | -18.30% | -22.54% |
| Return on Capital Employed (ROCE) | -26.90% | -42.20% | -12.70% | -19.90% | -35.00% | -21.30% |
| Earnings Yield | -8.14% | -31.34% | -61.07% | -47.17% | -46.40% | -17.09% |
| FCF Yield | -9.01% | -28.56% | -12.86% | -27.67% | -38.33% | -12.99% |
| Buyback Yield / Dilution | -2.38% | -40.80% | -78.47% | -2.57% | -114.60% | -460.40% |